Navigation Links
BioElectronics Corporation Announces New Website for Italian Market
Date:4/29/2008

ACTIPATCH.IT WEBSITE LAUNCHES

FREDERICK, Md., April 29 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced a new website, http://www.actipatch.it is now selling the ActiPatch products to the Italian market. TSS Medical, (Tecnica Scientifica Service), designed the site to reach both pharmacies and consumers in Italy. TSS Medical is a medical provider and distributor to Italy's retail pharmacies and is headquartered in Torino, Italy. Over 10,000 ActiPatch units were acquired by TSS Medical to initiate the retail product launch.

ActiPatch is a wafer thin patch with a microcurrent that has been shown to reduce pain and swelling and accelerate healing with no known side effects. The science behind ActiPatch is well-proven and has been successfully used as an office based therapy for many years. BioElectronics Corporation, through it's ActiPatch product, makes this technology available for use in any setting in an easy to wear patch that is placed directly over the soft tissue injury or surgical incision. ActiPatch is drug-free, simple to use and in most cases relieves pain and swelling very quickly. ActiPatch may also be a cost-effective alternative to OTC and prescription medications. Physicians are so impressed with the power of the patch that they are recommending ActiPatch for surgical recovery, sports injuries and other of aches, pains and soft tissue injuries.

Alessio Petricca, Head of Marketing and Operations of TSS Medical explains, "TSS Medical has had an exceptional response to the ActiPatch products, both at the ESRA Congress in Salerno and at the Congress of Chronic Pain in Genoa. The market potential for this innovative, drug-free therapy is enormous." The new website, http://www.actipatch.it provides an informative, easy to use sales channel for the ActiPatch products. Petricca promises that enhancements to the beautifully designed site are coming in the near future.

"We are watching the success of TSS Medical and their new website with great excitement," says Andrew Whelan, CEO of Bioelectronics Corporation. "This may be the beginning of our products becoming a worldwide choice for a drug free, cost-effective treatment for pain and swelling," adds Whelan.

About TSS Medical:

TSS Medical was established in 1998 and employs 40 sales agents. TSS is headquartered in Torino, Italy and maintains ISO 9000 TUV certification. The company distributes medications and medical devices for postoperative recovery and chronic pain for such leading companies as On Q, Vertis PNT, Anodyne Therapy and others.

For more information visit http://www.tssmedical.com.

About BioElectronics:

BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

Contact: Patricia Baker

413-623-0950

pbaker@bigpictureagency.com


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond
2. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
3. BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11
4. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
5. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
6. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
7. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
8. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
9. Torchmark Corporation Declares Dividend
10. Steris Corporation Announces the Appointment of Two New Directors
11. Digirad Corporation Reports Financial Results for First-Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
Breaking Medicine Technology: